Related Experiment Video
Updated: Jun 5, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution
Summary
Survival outcomes for extremity soft tissue sarcoma (ESTS) patients have improved significantly over time. This study shows better sarcoma-specific mortality and local recurrence rates in recent treatment periods.
Area of Science:
- Oncology
- Surgical Oncology
- Sarcoma Research
Background:
- Extremity soft tissue sarcoma (ESTS) management at a reference institution.
- Assessing temporal trends in patient outcomes.
Purpose of the Study:
- To evaluate changes in survival rates for ESTS patients over time.
- To identify improvements in outcomes for localized adult-type ESTS.
Main Methods:
- Retrospective review of 1094 ESTS patients treated between 1987-2007.
- Categorization into four 5-year treatment periods.
- Calculation of crude cumulative incidence for mortality, local recurrence, and distant metastases.
Main Results:
- Significant improvements in sarcoma-specific mortality (15% to 6%) and local recurrence (23% to 9%) in the latest period (period 4).
- Enhanced 5-year distant metastases-free survival observed in the recent period.
- Improved survival post-metastasis in the later treatment cohort.
Conclusions:
- Sarcoma treatment outcomes at reference institutions show improvement over time.
- Subtle advancements in sarcoma care likely contribute to better patient results.
- Acknowledges potential biases from retrospective analysis and learning curves.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...